ElevateBio Appoints Christopher Murphy as Chief Executive Officer and Member of the Board of Directors [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Christopher Murphy, Chief Executive Officer, ElevateBio WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced the appointment of Christopher Murphy as Chief Executive Officer (CEO) and member of its Board of Directors. He will succeed Ger Brophy, Ph.D., who has served as interim CEO since May 2025, and will continue to serve as an advisor on strategy and technology to the Company. Chris brings more than 35 years of leadership and operational experience across both biopharmaceutical and manufacturing sectors. He has a strong track record of combining expertise in advanced therapeutic development and manufacturing with commercial and operations management to accelerate revenue growth and build scalable businesses. His expertise will be instrumental in guiding ElevateBio's next phase of growth, focusing on scaling the business through new and expanded partners
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Fetal Bovine Serum Market Size, Share & Trends Analysis Report 2025-2033 [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher wins contracts as pharma shifts production to US, CEO says [Yahoo! Finance Canada]Yahoo! Finance Canada
- Nalgene Outdoor Unveils Thrill & Motion: A High-Energy Color Collection for 2026 [Yahoo! Finance]Yahoo! Finance
- Global Platinum-Based Catalysts Market Intelligence Report 2025-2034 - Investments in Green Hydrogen, Electric Vehicles, and Sustainable Aviation Fuels Driving the Industry [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific (NYSE:TMO) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
TMO
Earnings
- 10/22/25 - Beat
TMO
Sec Filings
- 1/12/26 - Form 8-K
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- TMO's page on the SEC website